CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $78,588,440
- in 8 filings, $78.6M under 10b5-1 plans
Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
- Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
- Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
- Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
- Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-30 | Paolini John F. CHIEF MEDICAL OFFICER | Sale 10b5-1 | −2,155 | $97.77 | $211K | 69,922 |
| 2026-10-30 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise · Share Option 10b5-1 | −38,545 | 6,455 | ||
| 2026-10-30 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise · Share Option 10b5-1 | −39,042 | 11,958 | ||
| 2026-10-30 | Patel Sanj K CHAIRMAN & CEO | Option exercise 10b5-1 | +47,530 | $8.83 | $420K | 999,324 |
| 2026-10-30 | Patel Sanj K CHAIRMAN & CEO | Sale 10b5-1 | −41,169 | $92.01 | $3.8M | 958,155 |
| 2026-10-30 | Patel Sanj K CHAIRMAN & CEO | Sale 10b5-1 | −18,685 | $92.77 | $1.7M | 939,470 |
| 2026-10-30 | Patel Sanj K CHAIRMAN & CEO | Sale 10b5-1 | −15,903 | $93.62 | $1.5M | 923,567 |
| 2026-10-30 | Patel Sanj K CHAIRMAN & CEO | Sale 10b5-1 | −8,888 | $94.72 | $842K | 914,679 |
| 2026-10-30 | Patel Sanj K CHAIRMAN & CEO | Sale 10b5-1 | −4,490 | $95.97 | $431K | 910,189 |
| 2026-10-30 | Patel Sanj K CHAIRMAN & CEO | Sale 10b5-1 | −2,316 | $97.34 | $225K | 907,373 |
| 2026-10-30 | Patel Sanj K CHAIRMAN & CEO | Sale 10b5-1 | −1,440 | $98.16 | $141K | 905,933 |
| 2026-10-30 | Patel Sanj K CHAIRMAN & CEO | Option exercise · Share Option 10b5-1 | −47,530 | 142,470 | ||
| 2026-10-30 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise 10b5-1 | +4,689 | $10.76 | $50K | 33,751 |
| 2026-10-30 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise 10b5-1 | +3,932 | $11.10 | $44K | 37,683 |
| 2026-10-30 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise 10b5-1 | +7,209 | $11.97 | $86K | 44,892 |
| 2026-10-30 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise 10b5-1 | +4,065 | $17.76 | $72K | 48,957 |
| 2026-10-30 | Megna Michael R CHIEF ACCOUNTING OFFICER | Sale 10b5-1 | −6,030 | $91.87 | $554K | 42,927 |
| 2026-10-30 | Megna Michael R CHIEF ACCOUNTING OFFICER | Sale 10b5-1 | −6,831 | $92.77 | $634K | 36,096 |
| 2026-10-30 | Megna Michael R CHIEF ACCOUNTING OFFICER | Sale 10b5-1 | −9,508 | $94.20 | $896K | 26,588 |
| 2026-10-30 | Megna Michael R CHIEF ACCOUNTING OFFICER | Sale 10b5-1 | −3,705 | $94.86 | $351K | 22,883 |
Page 5 of 74 · 1,467 trades